Constitutive production of cytokines was observed in 3 o£ 12 ylb T cell lines derived from murine epidermis and correlated with the expression of the Cy4, V66 T cell receptor (TCR) . After adaptation of one of the lines (T195/BW) to serum-free culture conditions, cessation of the "spontaneous" production of interleukin 4 (IJ. 4) was observed and 11=4 production could then be induced by the addition ofRGD-containing extracellular matrix (ECM) proteins to the culture. The response to the ECM proteins could be completely inhibited by a mAb to the murine vitronectin receptor (VNR). However, the induction of IL-4 production could also be inhibited by anti-CD3 and by an anti-clonotypic mAb to the TCR-y/b of T195/BW As TCR-ylb loss mutants of T195/BW also failed to respond to ECM proteins, these data demonstrate that engagement of the VNR by its ligand is necessary, but not sufficient, for the induction of IL4 production. Furthermore, the VNR is expressed by many other T cell clones (both y/b and x//3), none of which produce lymphokines constitutively. Taken together, these observations strongly favor the view that not only is coexpression of the VNR and TCR required for the induction of IL4 production, but that the TCR must also be engaged by its ligand, most likely a cell surface antigen expressed by the hybridoma itself.
T lymphocytes can be divided into two major lineages based on the molecular characteristics of their receptors . The major subpopulation of peripheral T lymphocytes express ct/a chains and recognize peptide antigens in association with either MHC class I or class 11 molecules . Although numerous recent studies have documented the existence of a second subpopulation of lymphocytes that express TCR y1b chains, a consensus view does not exist either concerning the nature ofthe antigen recognized by the TCR-y/b or the nature of the restriction element, if any, utilized by this population of cells (1) . A number of laboratories have reported the characteristics ofy/b clones/lines that recognize allo-and self-MHC including both class 1(2, 3), class 11(4), and nonclassical MHC antigens (5) (6) (7) . Certain y/b T cell clones have been generated that recognize conventional protein antigens (8, 9) and studies from several laboratories have suggested that y/b T cells may play a unique role in host defense against certain bacterial infections because their receptors are skewed to recognize a set of bacterial antigens (10) (11) (12) (13) (14) , particularly mycobacterial heat shock proteins (15-17). Although it has been reported that protein antigen specific y1b T cell clones may use conventional MHC class 11 antigens (8) or nonclassical MHC antigens (9) as restriction elements, many antigenspecific -y1 b T cells demonstrate no specific MHC restriction (14) or no requirement for the addition ofnon-T APCs (15).
These latter results do not rule out the possibility that the clones present antigen to themselves and use an uncharacterized cell surface antigen as a restriction element that may exhibit limited polymorphism .
Because y/b T cells are predominantly CD4 -, CD8 -, an alternative approach to the analysis of y/b T cell function has been to define unique cell surface antigens, in addition to the TCR, which are expressed on this population of cells and might play a role in their function, possibly as accessory molecules for the recognition of antigen (18, 19) . During the course of such studies, we identified (20) two mAbs to a novel integrin on murine lymphoid cells that was expressed on many y/b T cell lines and hybridomas as well as on cilO T cell lines and chronically activated ulo T cells in vitro .
The antigen family of cell surface heterodimers consists of at least three groups ofcell surface antigens which are identified by their usage of a common a which is associated with one ofseveral ct chains (21) . The VLA antigens use the #1 chain, the leukocyte adhesion proteins the 02 chain, and the cytoadhesins the (33 chain . Recent studies have documented the existence of other (3 chains (22) (23) (24) . The integrin identified on murine cells by our mAbs mediated cell binding to the extracellular matrix (ECM)' proteins, fibronectin, fibrinogen, and vitronectin and adhesion could be completely inhibited by the tetrapeptide RGDS. Although the precise molecular relationship of this integrin to the proposed classification system of human integrins has not been determined, we have recently shown (24a) that this murine integrin is likely to be a member of the 03 family, most likely the vitronectin receptor (VNR) .
In this report, we characterize several . y/6 cell lines derived from murine dendritic epidermal T cells (DETC) that produce substantial amounts of cytokines in culture in the apparent absence ofstimulation by exogenous agents. We demonstrate that this "spontaneous" production of cytokines requires the expression of the VNR and the interaction of the VNR with RGD-containing ECM proteins . Furthermore, this phenomenon is associated with the usage of the Cy4, V66 TCR and is absolutely dependent on expression of this TCR. Collectively, these data strongly suggest that the VNR plays a critical role as an accessary molecule in the stimulation of the C-y4, VS6 subset of cells.
Materials and Methods
CeII Lines. The DETC lines Y93A, Y245, and the T195/BW hybridoma have been previously described (25) (26) (27) (28) and are grown in RPMI 1640 supplemented with 10% FCS, 5 mM Hepes, 1 mM sodium pyruvate, nonessential amino acids, 2 mM glutamine, penicillin/streptomycin, and 5 p.M 2-ME (CM-RPMI) . The T195 cell line was grown in CM-RPMI supplemented with 20% rat Con A supernatant . Each adherant line was removed from plastic by treatment with PBS and 0.02% EDTA before resuspension in CM-RPMI . DETC were also grown in AIM V media (Gibco Laboratories, Grand Island, NY) without serum, but otherwise supplemented as described for RPMI-CM . CTLL cells were maintained as previously described (29) . CT4S was grown in CM supplemented with 500 U/ml rI1,4 and the DA-1 line was grown in 5% WEHI-3 supernatant .
Reagents. Vitronectin, fibronectin, and PepTite 2000 were obtained from Telios Pharmaceuticals, Inc. (San Diego, CA) . Rat collagen IV, BSA, PMA, and ionomycin were purchased from Sigma Chemical Co., St. Louis, MO. Peptides (RGDS, GRGDS, RGES) used in inhibition experiments were purchased from Peninsula Laboratories, Inc . (Belmont, CA). Proteolytic fragments ofhuman fibronectin were kindly provided by Joyce Czop (Harvard Medical School, Boston, MA) and have previously been described (30) .
Production of Lymphokine-containing Supernatants. DETC were incubated at a concentration of 2.5 x 105 in 1.0 ml of CM-RPMI or AIM V media in 24-well cluster plates overnight . Supernatants were harvested and frozen at -20°C before assay for lymphokines. Wells of 24-well cluster plates were incubated overnight at 37°C with 1.0 ml of ECM protein or mAb in PBS . Wells were subsequently washed three times with PBS before use.
Lymphokine Assays. 11,2 was assayed on CTLL cells responsive toboth IL,2 and IIr4 as previously described (29) . IL-4 was specifically assayed using the CTAS cell that is responsive to 11,4, but not IT,2 (29) . Granulocyte/macrophage CSF (GM-CSF) was assayed using DA-1 cells. Supernatants were titrated by doubling dilutions in 96-well microtiter plates before adding the indicator cells (5,000 cells/well, total volume of 200 pl) . After 48 h, 1.0 pCi of ['H]TdR was added and plates were harvested 5 h later . Units were defined as the reciprocal of the dilution ofsupernatant (x 100)
232
The Vitronectin Receptor and Lymphocyte Activation required to induce a half-maximal proliferative response of the indicator cell line.
Production of TCR Loss Mutants of T1951BW. TCR loss mutants of T195/BW were prepared by exposing cells to ethyl methane sulphonate (Sigma Chemical Co.), 200 pg/ml for 24 h at a cell concentration of 2.5 x 105/ml . Mutagenized cells were grown in CM-RPMI for 7dbefore selection using the F10/56 antibody (1/100 diluted ascites) in the presence of rabbit complement (1/10 dilution; Cedarlane Laboratories, Hornby, Ontario). Negative selection with F10/56 and complement was repeated on three successive days to yield a preparation that was 20-30% positive by staining with F10/56 . These cells were then cloned by limiting dilution and the clones were subsequently screened by staining with F10/56-FITC and analysis using a FACSCAN (Becton Dickinson & Co., Mountain View, CA) .
Purification of mAbs. The anti-clonotypic mAb F10/56 was generated by immunization of a hamster with T195/BW cells. Further characterization of this mAb will be presented elsewhere (Roberts, K., and E. M. Shevach, manuscript in preparation) . The mAbs H1.2F3 (18), 2C11 (31) and H9 .2 (20) were purified from hybridoma supernatants on protein A-Sepharose amity columns (Pharmacia Fine Chemicals, Piscataway, NJ) . Ml/9.3.4.HL .2 (Ml/9 ; 32) and 8.18 (20) were purified on a mouse anti-rat « (MAR 18.5) affinity column. The hamster mAb F10/56 was purified on a mouse anti-rat rc (RG7/7, cross-reactive with hamster ; 33) affinity column . Antibody was subsequently eluted from the columns at pH 4.3 and dialyzed against PBS . Contaminant fibronectin was removed by passage ofaffinity pure antibody preparations over heparin agarose columns (Sigma Chemical Co.) before use in functional experiments. (data not shown) . Interestingly, all three of the T cell lines/hybridomas that were capable of spontaneous cytokine production have closely related TCRs insofar as they are known to express both Vy1 .1 C-y4 and VS6 chains (25, 27, 28) . T195 and T195/BW (a hybridoma made by fusion of this line to BW5147) only express the C-y4, VS6 receptor, while Y93A and Y245 also have functional mRNA for Cy1 and a second TCR composed of Cy1, VS6 chains can be immunoprecipitated from surface-labeled cells (28) . The nine other DETC lines and hybridomas that did not produce lymphokines in the absence of stimulation all express the V-y3Cy1 and V61 chains (27) .
Results

Inhibition ofthe
Since these data suggested a correlation between the expression ofthe Cy4, V66 TCR and the phenotype ofconstitutive lymphokine production, we sought further evidence Supernatants from DETC cultures were assayed for lymphokine . Results are expressed as cpm and represent [3H]TdR incorporation of indicator cells using 6.25% DETC supernatant . DA-1 cells were used in Exp. 1 and CTLL used in Exps. 2 and 3. In Exps. 1 and 2, purified mAbs were either added to the culture medium or immobilized on plates (used at 20 wg/ml in both cases). In Exp . 3, antibodies were added to the culture media (5.0 pg/ml).
that the TCR was involved . Inhibition of GM-CSF production by both Y93A and Y245 cell lines was observed when these lines were cultured in the presence of soluble, but not immobilized, anti-CD3 ( in a large panel of T cell hybridomas derived from newborn thymus and spontaneous IL2 production and a similar inhibition by soluble anti-CD3. Although stimulation via the TCR may lead to growth arrest of T cell hybridomas (34), the proliferation of T195/BW was identical in the presence or absence of anti-CD3. In subsequent experiments, T195/13W was used exclusively because of its ease of growth, its susceptibility to inhibition by anti-CD3, and the availability of the anti-clonotypic mAb F10/56 . Activation Properties of T1951BW Cultured in Serum Free Medium. The ability of anti-CD3 and the anti-clonotypic mAb to inhibit IL4 production by T195/BW when used in soluble, but not plate-bound, form raised the possibility that the anti-CD3/TCR mAbs inhibited T cell activation by blocking the recognition of antigen present in the culture medium or present on the T cell hybridoma itself. T195/BW was therefore adapted to "serum-free" culture conditions (AIM V medium) to assess the possible involvement of an antigen present in FCS . Cells grown in AIM V proliferated as well as those grown in RPMI containing 10% FCS or AIM V supplemented with FCS (data not shown) . However, no IL4 was detected in the supernatants of T195/BW grown in AIM V, while supplementation of the AIM V with FCS resulted in ILA production ( Table 2 ). In contrast to the lack of effect of immobilized anti-CD3 on T195/13W cells grown in serum, the hybridoma cells grown in AIM V without FCS could be induced to produce levels of 114 with either immobilized anti-CD3 or the clonotypic mAb, F10/56, comparable to those observed by serum stimulation (Table 2 ). Immobilized mAbs specific for the VNR (H9 .2) and the murine CD45 homologue (M1.9), antigens expressed by the hybridoma, failed to induce lymphokine production.
The Serum Components Responsible for 11,4 Production are ECM Proteins. One of the most striking differences between T195/BW cells grown in serum and T195/BW grown in AIM V was that the former grew in a strongly adherent monolayer, while the latter grew in suspension culture. Furthermore, addition of serum to the AIM V media induced rapid adhesion of the T195/BW cells to plastic and subse- T195/13W cells were cultured in AIM V on plates coated with antibodies (20 ttg/ml) or in the presence of FCS (10%) or PMA (10 ng/ml.) and ionomycin (400 ng/ml .). Supernatants were harvested after 18 h and assayed on CTAS for IL-4 content . (Table  3) . Collectively, these observations raised the possibility that cell adherance was related to lymphokine production in FCS containing media. To address this issue, T195/13W cells, which had been grown in AIM V for 3 wk, were cultured in AIM V on plates coated with various ECM proteins. ILA production was observed (Table 3) when the hybridoma was incubated overnight on plates coated with human fibronectin, mouse fibronectin, or human vitronectin (and fibrinogen, data not shown), but not with rat collagen or BSA. Thus, the specificity of the induction of IL4 production by the ECM proteins is identical to the previously described (20) specificity of the adhesion of T195/BW to ECM proteins mediated by the integrin identified by mAb H9 .2 . It has previously been demonstrated that the amino acid tripeptide, RGD, is one of the cell attachment sites on the fibronectin, fibrinogen, and vitronectin molecules (35, 36) .
To further evaluate whether ECM proteins containing RGD
were the only components in serum that mediated the activation of T195/BW, we examined the effect of addition of the synthetic peptide RGDS on the constitutive production of IL-4 by this cell when it is maintained in serum containing
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The Vitronectin Receptor and Lymphocyte Activation T195/BW cells grown in RPMI containing 10% FCS were washed and then recultured in RPMI containing 10% FCS (Exp . 1) . In Exp. 2, T195/BW cells grown in AIM V were cultured in AIM V on fibronectin (1 .0 14g/ml) coated plates, in AIM V supplemented with 5% FCS, or in AIM V on plates coated with anti-CD3 (2C11, 20 Wg/ml) . peptides were added to the culture medium at the concentrations indicated. After 18 h of culture, supernatants were assayed for IL-4 content as in the legend to medium. The addition of RGDS, but not the control peptide RGES, inhibited by >95% the production of IL4 by T195/BW in serum containing medium ( was not affected by the RGDS peptide, these results demonstrate that the inhibition of the response to serum or ECM proteins by RGDS is specific, and further demonstrate that RGDS induced inhibition ofIL4 production is not secondary to the delivery of a negative signal. The RGDS Sequence Is Sufficient to Stimulate the T195/BW Hybrid. The minimum portion of the fibronectin molecule required to stimulate T195/13W was investigated using proteolytic fragments of human fibronectin ( Table 5 , Exp. 1). Costar wells were coated with each of the fibronectin fragments and then blocked with BSA . Any fragment containing the cell attachment domain was sufficient to trigger ILA production and these fragments were as efficient as the whole fibronectin molecule. Fragments containing the gelatin binding site or the heparin binding site failed to stimulate; a very low level of stimulation was observed using the 29-kD NH2-terminal fragment.
The stimulatory sequence in fibronectin was further defined by using a commercial peptide of 2,000 daltons molecular weight (Pep Tite 2000) that contains the RGDS cell attachment sequence and a highly charged sequence of amino acids that facilitate its binding to plastic . Plates coated with PepTite 2000 (1.0 l, tg/ml) were as effective as plates coated with the intact fibronectin molecule (1.0 14g/ml) in the induction of IL4 production by T195/BW (Table 5, Exp. 2). This result is most consistent with the view that sequences outside the cell attachment site on ECM proteins are not required to trigger T195/BW Furthermore, it is also very unlikely that the TCR plays any direct role in the recognition of the ECM proteins as both the integrin and the TCR would then be required to simultaneously bind to the RGDS sequence.
The VNR Identified by mAb HQ.2 Mediates the Stimulation of T1951BW by ECMProteins. One likely candidate for the integrin responsible for the activation ofT195/BW cells was the heterodimer recognized by mAbs H9.2 and 8.18, which we have previously shown to be expressed on many of the y/S DETC cell lines as well as on T195/BW hybridoma cells (20) . T195/BW cells maintained in serum free medium were stimulated with immobilized murine fibronectin or by supplementing the medium with FCS (5% final) . IL4 production induced by either fibronectin or serum was completely inhibited by mAb H9.2 (Table 6 ), while mAb 8.18 which recognizes a distinct site on the 120-kD fragment o£ the a chain of the integrin heterodimer produced much less inhibition. This result differs from the effects of these mAbs on cell adhesion where the simultaneous addition ofboth H9.2 and 8.18 was required to block adhesion (20) . The addition of anti-CD3 also resulted in complete inhibition ofIL4 produc-
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tion, while mAbs H1.2F3 (anti-CD69) and M1.9 (anti-CD45, data not shown), which are directed to other cell surface antigens expressed on the hybridoma, failed to inhibit . IL4 production could also not be inhibited by anti-MHC class I, anti-MHC class II, or anti-LFA 1 mAbs (data not shown) . Co-Expression ofthe TCR Is Requiredfor Integrin-mediated T Cell Activation. Although these studies strongly implicate the integrin defined by mAb H9.2 as the signal-transducing molecule involved in the induction of 1164 production by ECM proteins, they fail to explain why this response is so readily inhibited by anti-CD3 or the anti-clonotypic mAb. To more accurately define the role of the TCR in this process of activation, TCR loss mutants were generated from the T195/BW hybrid by chemical mutagenesis followed by negative selection with the anti-clonotypic mAb P10/56 and complement . Five cloned lines were selected on the basis of their lack of reactivity with the anti-clonotypic mAb by FACS analysis and all expressed levels of the integrin comparable to the parental cell line (data not shown) . The clones appeared to retain the phenotypic characteristics of the parental line as they continued to grow adherent and to spread on plastic. Northern blot analysis revealed that all five mutant lines had lost expression of the TCR y chain (data not shown) . None of the mutants produced I1J4 constitutively ( Table 7) or after stimulation with immobilized F10/56, but all were capable of IIJ4 production after stimulation with the combination of PMA and ionomycin . These results demonstrate an absolute requirement for coexpression ofthe TCR for activation of T195/BW by ECM proteins.
Discussion
The studies described in the present report are an extension of our previous reports on the characteristics of y/S T cell lines derived from murine skin (25) (26) (27) and have specifically addressed the mechanisms responsible for the production of cytokines by several DETC lines in the absence of exogenous stimulation . 3 of 12 DETC lines generated from C3H mouse skin constitutively produced lymphokine. On closer investigation, two of the lines (Y93A and Y245) were shown to produce GM-CSF and one (T195) 114. After adaptation of the T195/BW hybridoma to serum-free culture conditions, cessation of the "spontaneous" production of IIr4 was observed and IIT4 production could then be induced by the ad- Five mutants failing to express the TCR epitope recognized by F10/56 were prepared as described. The TCR loss mutants and parental line were incubated overnight in RPMl containing 10% FCS, plates coated with F10/56 (20 Rg/ml), or PMA/lonomycin for 18 h. Culture supernatants were then analyzed for IL-4 content as described in Table 2 .
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The Vitronectin Receptor and Lymphocyte Activation dition of RGD-containing ECM proteins to the culture. The response to the ECM proteins could be completely inhibited by a mAb to the murine VNR . However, the induction of IIr4 production could also be inhibited by anti-CD3 and by an anti-clonotypic mAb to the TCRy/b of T195. As TCR y/b loss mutants of T195/BW also failed to respond to ECM proteins, these data demonstrate that engagement ofthe VNR by its ligand is necessary, but not sufficient, for the induction of IIs4 production and that the TCR-y/S also plays a role in the response to ECM proteins. One possible explanation for our findings was that the TCR y/S expressed by T195 recognized a non-RGD site on the ECM proteins as its ligand, and that engagement of this site by the TCR together with engagement of the RGD site by the VNR were both required for the induction ofHA production. The active components in serum were found to be the ECM proteins, vitronectin, fibronectin, and fibrinogen (data not shown) . Since the RGDS peptide was efficient at inhibiting lymphokine production by the hybridoma grown in the presence of serum, it would appear that proteins containing the RGDS sequence are the only components of serum that were responsible for triggering T195/BW. It is rather unlikely that the ECM proteins were serving as antigen for the TCRy/6 since fibronectin and vitronectin share minimal sequence homologies other than RGDS. Moreover, fibronectin only stimulated when firmly immobilized on plastic and no evidence could be obtained that soluble fibronectin could be processed and presented by the hybridoma cells (data not shown) . The ability of the synthetic 20 amino acid RGDS-containing peptide, PepTite 2000, to efficiently activate IIJ4 production is consistent with the view that RGDS is both necessary and sufficient for both adhesion and cell activation. Although it is formally possible that the VNR and the TCR could both recognize the RGDS sequence, we regard this possibility as unlikely.
The ability ofmAb H9.2 to completely inhibit the production of1174 by T195/BW strongly suggests that the integrin identified by this mAb is involved in the process of T cell activation. We believe that this integrin is the VNR because it is reactive with an antiserum to the human VNR and is not reactive with antisera specific for the human integrin /31 or /32 COOH-terminal amino acid sequences ; furthermore, in detergent extracts of T195/BW, all of the molecules reactive with mAb H9.2 are also reactive with an antiserum to the human /33 COOH-terminal sequence (24a).
Adhesion of the cells to the culture dish was insufficient to induce T cell activation as adhesion mediated by an immobilized mAb to the common leukocyte antigen (CD45) failed to induce IIr4 production. Thus, it is likely that the interaction and engagement of the VNR with immobilized, but not soluble, ECM proteins, lead to signal transduction mediated by the integrin. Integrins have been implicated as playing a role in adhesion, motility, hemostasis, development, induction of differentiation, and cytoskeletal reorganization (21, 37) . It is likely that integrins function as signal transducers because they interact with molecules of both the extracellular matrix and with the cytoskeleton and bind the cytoskeletal protein talin (38) . Although the biochemical basis for this interaction has not yet been determined, the failure of mutant integrin al chains that lack a cytoplasmic domain to localize efficiently in focal contacts even though the mutant integrins are exported to the cell surface and bind fibronectin (39) strongly implicates the cytoplasmic portion of the a chain in this process.
Although some evidence exists for the role of integrins in the enhancement of phagocytosis of opsonized particles by monocytes (40) , the induction of the respiratory burst in human neutrophils (41) , and the regulation of stromelysin gene expression in fibroblasts (42) , the ability of the integrins to function as signal transducers in the process of T cell activation and lymphokine production has not been exhaustively analyzed. Wacholtz et al. (43) have demonstrated that co-stimulation of resting CD4+ T cells with immobilized anti-CD3 can be enhanced by co-stimulation with an anti-LFA-1 mAb and that crosslinking of LFA1 and CD3 simultaneously produced a prolongation in the increase in [Ca2 +j; and enhancement of both IL2 production and proliferation. Similarly, Matsuyama et al. (44) have shown that fibronectin synergizes with suboptimal concentrations of anti-CD3 to induce a proliferative response of resting CD4+ T cells and that the stimulatory effects of fibronectin could be inhibited by RGDS and a mAb to VLA-5. In contrast to our findings, fragments of fibronectin containing the cell adhesion site alone were not as effective as the intact molecule in inducing T cell activation.
Although An alternative model that is most compatible with our data is that not only is coexpression of the VNR and TCR required for the induction of 11,4 production, but that the TCR must also be engaged by its ligand, most likely a cell surface antigen expressed by the hybridoma itself. A specific correlation between the spontaneous production of IL2 and expression of a TCR-y/b using Cy4 and frequently VS6 has been described (15, 50) in a large panel of T cell hybrids derived from newborn thymus. In the present report, the three cell lines that produced lymphokines "constitutively" in culture also expressed a TCR utilizing the Cy4 and V66 gene products. Taken together, these observations strongly favor theview that the combination ofCy4 with a restricted number of b chains (particularly VS6) results in expression of a TCR that is likely to recognize an autoantigen. However, the failure of the cell to be triggered in serum-free medium even under high density culture conditions suggests that the TCR expressed by T195/BW is oflow affinity and requires the VNR to function as an "accessory molecule" to produce a high affinity interaction in a manner similar to that proposed for CD4/CD8 and MHC class II/class I, CD2 and LFA3, as well as LFA-1 and ICAM-1 (51). However, in the case of 15) demonstrated that many of the hybridomas generated from newborn thymus that spontaneously produced IL-2 were also reactive with PPD from Mycobacterium tuberculosis and with a member of the heat shock family of proteins . Although these observations were interpreted as indicating that the physiologic ligand of the TCR-y/S is likely to be an autologous heat shock protein, probably a member ofthe GroEL family (17), it is also possible that certain subpopulations of y/6 T cells might recognize bacterial antigens as their physiologic ligand and use the VNR or another member of the integrin family as accessory molecules. Their reactivity with autologous heat shock proteins would then be considered to be a crossreaction . It is of particular interest that a number ofbacteria have been shown to interact with ECM proteins. Both fibronectin and fibrinogen bind to Staphylococcus aureus (53) (54) (55) as well as Calmette-Guerin bacillus (BCG) (56) and vitronectin binds to streptococci (57) . It has also recently been shown that the integrin 01 chains are receptors for invasin, a protein involved in the penetration of bacteria into nonphagocytic cells (58) . The combined use of certain -y/6 receptors together with the integrins may prove to be an important mechanism for the generation of host resistance to bacterial antigens. The VNR may play a particularly important role in this process as it is a promiscuous integrin that is capable ofinteracting with bacteria coated with one of several ECM patients or even bacterial antigens that contain an RGD sequence.
